PAR-2 activation peptide,
seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide,
SL-NH2,
SLIGRL-NH2,
SLIGRL-NH2,
171436-38-7,
H-SER-LEU-ILE-GLY-ARG-LEU-NH2,
Protease-Activated Receptor-2 Activating Peptide,
Ser-Leu-Ile-Gly-Arg-Leu-amide,
Ser-Leu-Ile-Gly-Arg-Leu-NH2,
Ser-Leu-Ile-Gly-Arg-Leu-NH(2),
SL-NH2,
Ser-Leu-Ile-Gly-Arg-Leu-amide trifluoroacetate salt,
SLIGRL-NH,
PAR-2-AP,
CHEMBL238078,
BDBM85517,
HY-P1308,
ZINC26468553,
AKOS024456619,
PAR-2 (1-6) amide (mouse, rat),
LS-191961,
CAS_171436-38-7,
CS-0029354,
PAR-2 (1-6) amide (mouse, rat) trifluoroacetate salt,
PAR-2 (1-6) amide (mouse, rat) trifluoroacetate salt, >=97% (HPLC),
PAR-2 activation peptide,
PAR2-AP,
CID9831050,
CID 9831050,
C112356,
seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide,